Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Buildings (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Buildings for 11 consecutive years, with $7.3 billion as the latest value for Q4 2025.

  • Quarterly Buildings rose 10.47% to $7.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 billion through Dec 2025, up 10.47% year-over-year, with the annual reading at $7.3 billion for FY2025, 10.47% up from the prior year.
  • Buildings for Q4 2025 was $7.3 billion at Bristol Myers Squibb, up from $7.1 billion in the prior quarter.
  • The five-year high for Buildings was $7.3 billion in Q4 2025, with the low at $5.6 billion in Q1 2021.
  • Average Buildings over 5 years is $6.3 billion, with a median of $6.2 billion recorded in 2023.
  • The sharpest move saw Buildings fell 4.04% in 2021, then grew 10.47% in 2025.
  • Over 5 years, Buildings stood at $5.9 billion in 2021, then increased by 0.39% to $5.9 billion in 2022, then grew by 9.71% to $6.5 billion in 2023, then increased by 1.32% to $6.6 billion in 2024, then increased by 10.47% to $7.3 billion in 2025.
  • According to Business Quant data, Buildings over the past three periods came in at $7.3 billion, $7.1 billion, and $6.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.